Foundation Medicine-B (02616.HK) proposes to place a total of 100 million shares, raising approximately HK$4.67 billion.

iFast Financial News App reported that Cornerstone Pharmaceuticals-B (02616.HK) announced on July 8, 2025, that the company plans to issue a total of 100 million shares for sale, accounting for approximately 6.83% of the enlarged issued share capital after the issuance and distribution of all saleable shares. The sale price for each share is 4.72 Hong Kong dollars.